Professor of Clinical Pharmacology
Radboud University Medical Center
Dr. Saskia de Wildt, MD, PhD is currently full professor of Clinical Pharmacology, combining this appointment with clinical care in the Pediatric Intensive Care at Radboud University in Nijmegen and is primary investigator at Erasmus MC in Rotterdam, the Netherlands. She earned her medical degree at Maastricht University in the Netherlands (1996) and her PhD degree from Erasmus University Sophia Children’s Hospital Rotterdam, the Netherlands, on ‘Developmental aspects of midazolam metabolism’ (2001). She next trained in Pediatrics and Pediatric Intensive Care, also in Rotterdam and at the Hospital of Sick Children in Toronto, while also obtaining the American and Dutch Board of Clinical Pharmacology certification as clinical pharmacologist. She has published over 160 peer-review international papers and received over 8 million euros PI research funding. Her research, largely supported by grants from ZonMW, EU and the Bill and Melinda Gates Foundation, aims to better understand the impact of age, disease and genetics on drug disposition and to individualize drug dosing in children, with a focus on pain&sedation and acute kidney injury. She participates at leadership level in two EU H2020 grants aimed to develop EU-wide infrastructure to study drugs in children. She is also workpackage leader for Scientific Advice and Innovation of the EU Innovative Medicines Initiative project Conect4children (140 million euros), also aimed to build EU pediatric clinical trial infrastructure. Dr. de Wildt is director of the Dutch Knowledge Center for Pharmacotherapy in Children and as such responsible for the Dutch Pediatric Drug Handbook and its international affiliates (‘kinderformularium.nl’).
Disclosure information not submitted.
Friday, September 16, 2022
10:00 AM – 4:00 PM ET
.png)